IRIS
RICCIARDI, GIUSEPPINA ROSARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 768
EU - Europa 645
AS - Asia 247
SA - Sud America 150
AF - Africa 12
OC - Oceania 1
Totale 1.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 762
IE - Irlanda 175
SE - Svezia 169
BR - Brasile 135
CN - Cina 106
IT - Italia 89
SG - Singapore 81
FI - Finlandia 31
PL - Polonia 28
DE - Germania 27
FR - Francia 27
GB - Regno Unito 21
AT - Austria 20
IN - India 20
UA - Ucraina 20
BE - Belgio 19
HK - Hong Kong 8
AR - Argentina 5
CZ - Repubblica Ceca 5
VN - Vietnam 5
CO - Colombia 4
MA - Marocco 4
DZ - Algeria 3
ID - Indonesia 3
IQ - Iraq 3
RU - Federazione Russa 3
TR - Turchia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
EC - Ecuador 2
GR - Grecia 2
IR - Iran 2
LV - Lettonia 2
MX - Messico 2
PK - Pakistan 2
PY - Paraguay 2
ZA - Sudafrica 2
AO - Angola 1
AU - Australia 1
BO - Bolivia 1
CA - Canada 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
IM - Isola di Man 1
JP - Giappone 1
KG - Kirghizistan 1
KR - Corea 1
LK - Sri Lanka 1
LT - Lituania 1
ML - Mali 1
NL - Olanda 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
RO - Romania 1
TM - Turkmenistan 1
TN - Tunisia 1
Totale 1.823
Salva come PNG Salva come JPEG
Città #
Dublin 174
Chandler 159
Nyköping 86
Ashburn 77
Singapore 61
Jacksonville 54
Ann Arbor 52
Beijing 49
Messina 29
The Dalles 29
New York 28
Warsaw 28
Princeton 25
Medford 24
Cambridge 23
Brussels 19
Dearborn 18
Des Moines 18
Vienna 18
Pune 17
Boardman 13
Los Angeles 12
Woodbridge 12
Jinan 9
Hong Kong 8
Lancaster 8
Milan 8
Nanjing 8
San Mateo 8
Helsinki 6
São Paulo 6
Tianjin 6
Wilmington 6
Dong Ket 5
Giardini-Naxos 4
Hangzhou 4
Hebei 4
Leawood 4
Shenyang 4
Bremen 3
Campinas 3
Duque de Caxias 3
Frankfurt am Main 3
Fuzhou 3
Goiânia 3
Jakarta 3
Jiaxing 3
Joinville 3
Nanchang 3
Ningbo 3
Olomouc 3
Tashkent 3
Trepuzzi 3
Araçatuba 2
Asunción 2
Athens 2
Blida 2
Bogotá 2
Casablanca 2
Catania 2
Curitiba 2
Düsseldorf 2
Girifalco 2
Grammichele 2
Hyderabad 2
Indaiatuba 2
Istanbul 2
Juiz de Fora 2
Lissone 2
Maceió 2
Monmouth Junction 2
Montes Claros 2
Osasco 2
Ozzano dell'Emilia 2
Ribeirão Preto 2
Riga 2
Rio das Ostras 2
Rio de Janeiro 2
Salt Lake City 2
Santa Bárbara d'Oeste 2
São Bernardo do Campo 2
Taizhou 2
Washington 2
Zhengzhou 2
Acireale 1
Alegrete 1
Alfenas 1
Ambrolauri 1
Antakya 1
Araguari 1
Araraquara 1
Araxá 1
Ardabil 1
Ashgabat 1
Atibaia 1
Ba'qubah al Jadidah 1
Barbacena 1
Belo Horizonte 1
Ben Arous 1
Beni Mellal 1
Totale 1.243
Salva come PNG Salva come JPEG
Nome #
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 123
Androgen Receptor (AR), E-Cadherin, and Ki-67 as emerging targets and novel prognostic markers in triple-negative breast cancer (TNBC) patients 109
Folate pathway implications in advanced Non Small Cell Lung Cancer (NSCLC): impact of thymidylate synthase (TS) promoter and methlylenetetrahydrofolate reductase (MTHFR) C677T and A1298C variants expression on patients’ outcome and correlation with p53 codon 72 mutations. 99
Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: Two case reports. 97
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications. 93
Activity and safety of gefitinib and erlotinib in metastatic non-small cell lung cancer (NSCLC): A comparative analysis. 89
Preliminary study of pre-metastatic niche (PMN) in nonmetastatic nodes for the assessment of metastasis risk in breast cancer (BC). 86
Androgen receptor (AR), E-cadherin, and Ki-67 as prognostic markers in triple-negative breast cancer (TNBC). 83
Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. 77
Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients. 73
The changing scenario of 1st line therapy in non-oncogene addicted NSCLCs in the era of immunotherapy 71
Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study. 68
Role of interleukin-23 circulating levels increase in resected colorectal cancer before and after chemotherapy: preliminary data and future perspectives. 67
Uncommon breast metastatic site and eribulin responsiveness in a heavily pretreated patient 62
Observational study to evaluate the pattern of trastuzumab (T) use and survival outcomes in HER2-positive (HER2+) early breast cancer (EBC): Regional Southern Italy experience. 61
Safety of trastuzumab, alone or in combination, in elderly patients with HER2-positive breast cancer: A 5-year case series. 61
Correlation between serum magnesium levels and skin toxicity during cetuximab treatment in squamous cell carcinoma of head and neck cancer (SCCHN): the role of weekly intravenous magnesium supplementation. 60
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) 58
Pegylated liposomal doxorubicin in combination with gemcitabine in elderly women with locally advanced or metastatic breast cancer: safety and activity results of our clinical experience. 58
Infra-centimetric HER2 positive Breast Cancer: The Southern Italy Experience. 56
Multicenter study in women with infracentimetric HER2 positive breast cancer: The Regional Sicilian experience. 53
null 52
Management and treatment of triple-negative breast cancer patients from the NEMESI study: An Italian experience. 51
Safety of trastuzumab-containing therapies in elderly women with metastatic breast cancer. 50
Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals 27
The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population. 26
Low and Ultra-Low HER2 in Human Breast Cancer: An Effort to Define New Neoplastic Subtypes 24
null 22
Totale 1.856
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.699
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202033 0 0 0 0 0 0 0 0 0 0 26 7
2020/2021200 16 0 33 24 18 18 13 7 11 22 25 13
2021/2022189 3 21 5 5 3 4 10 6 3 47 23 59
2022/2023551 39 61 21 45 47 63 9 33 218 1 11 3
2023/2024203 7 21 11 12 9 70 57 2 2 3 2 7
2024/2025401 5 6 9 30 20 33 8 103 143 38 6 0
Totale 1.856